Tata Consultancy Services has launched TCS ADD™ AgentHub, a role-based, enterprise-ready AI platform designed to enable pharmaceutical companies to deploy agentic AI across drug development at scale.
The platform is designed to support clinical trials and pharmacovigilance while addressing the governance, oversight and auditability requirements of highly regulated pharmaceutical environments.
Pharmaceutical companies face growing complexity in applying AI across research and development, driven by increasing data volumes, fragmented systems and evolving regulatory requirements. TCS ADD™ AgentHub provides a framework in which AI agents operate with defined roles, oversight and built-in auditability. Pharma companies can configure and deploy AI agents across clinical workflows with limited integration and implementation effort.
Built on the TCS ADD™ framework, the platform is designed to deliver operational benefits across drug development and safety functions. Solutions powered by the platform have demonstrated up to 40% efficiency gains in clinical data management activities, up to 30% reduction in clinical study build effort through metadata-driven automation, and up to 30% cost savings in end-to-end safety case processing. AI-powered safety agents can also reduce quality control effort by up to 50%.
TCS ADD™ AgentHub supports a human + AI operating model, in which AI agents are embedded into enterprise workflows while humans retain responsibility for governance and decision-making.
Debashis Ghosh, President, Life Sciences and Healthcare, TCS, said, “TCS ADD™ AgentHub is a role-based, enterprise-ready, and trusted AI platform that will enable our customers to accelerate drug development using agentic AI at scale. It enables a shift from reactive to proactive, scalable, and audit-ready operations amidst an ever-changing regulatory environment. TCS’ strategy is to move towards autonomous enterprise functions where an AI agentic workforce operates alongside humans, driving innovation in drug development and improving patient safety.”
The platform supports workflows across clinical development and pharmacovigilance, including ICSR intake, data entry, coding, review and literature analysis; study design, protocol digitisation and clinical data review; SDTM transformation; and medical monitoring assistance. TCS said its catalogue of AI agents can be deployed progressively based on an organisation’s requirements and technology landscape.
By standardising the deployment of AI agents across these processes, TCS ADD™ AgentHub is designed to improve productivity while allowing scientific teams to focus on higher-value activities.